Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)

NCT04485156 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

926

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis, Pulmonary

Interventions

DRUG: High-dose rifampicin
DRUG: Isoniazid
DRUG: Pyrazinamide
DRUG: Ethambutol
DRUG: Rifampicin

Sponsor

Seoul National University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]